Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Neha Sachdev, MDJanet Williams, MA
Diabetes Care begins with Diabetes Prevention
© 2018 American Medical Association. All rights reserved.
Objectives
• Describe the clinical practice burden and trends in type 2 diabetes
• Review evidence for diabetes prevention
• Describe AMA’s Stages of Engagement
2
© 2018 American Medical Association. All rights reserved.
Epidemiology and Clinical Burden of Prediabetes
3
© 2018 American Medical Association. All rights reserved.
Alex
4
• 2003 Prediabetes age 55
© 2018 American Medical Association. All rights reserved.5
• 2003 Prediabetes age 55
• 2006 Type 2 Diabetes
GlucometerLancetsTest StripsDiabetes EducationMetforminStatinAspirin?ACE-I?Referral OphthalmologyReferral PodiatryOffice Visit q 3 monthsLabs and Urine
Alex
© 2018 American Medical Association. All rights reserved.6
• 2003 Prediabetes age 55
• 2006 Type 2 Diabetes
• 2016 Retinopathy
Alex
© 2018 American Medical Association. All rights reserved.7
• 2003 Prediabetes age 55
• 2006 Type 2 Diabetes
• 2016 Retinopathy
• 2020 CKD
Referral NephrologyPrior authorizationsOngoing refillsOngoing labsMedical complicationsAnemiaOsteoporosisEdema
Alex
© 2018 American Medical Association. All rights reserved.National Center for Chronic Disease Prevention and Health PromotionDivision of Diabetes Translation
Adults with Diagnosed Diabetes, Age-Adjusted Percentage
Disclaimer: This is a user-generated report. The findings and conclusions are those of the user and do not necessarily represent the views of the CDC.www.cdc.gov/diabetes/dataSource:
Americans have diabetes
30+MILLION
© 2018 American Medical Association. All rights reserved.National Center for Chronic Disease Prevention and Health PromotionDivision of Diabetes Translation
Adults Diagnosed with Diabetes in Ohio, Age-Adjusted Percentage
Disclaimer: This is a user-generated report. The findings and conclusions are those of the user and do not necessarily represent the views of the CDC.www.cdc.gov/diabetes/dataSource:
© 2018 American Medical Association. All rights reserved.
Health burden of diabetes
10
100%more likely to
develophypertension1
80%more likely to
be hospitalized for heart attack2
50%more likely to
be hospitalized for a stroke2
70%more likely todie from heart
disease or stroke2
Compared to people without diabetes, those with diabetes are:
© 2018 American Medical Association. All rights reserved.11
Cost of diabetes
© 2018 American Medical Association. All rights reserved.
Total Medical Expenditure In The Years Leading to Diabetes Diagnosis
12
$ prior to diabetes diagnosis
(2010-2013)
Diabetes Diagnosis (2014)
$ over same 5 year period
(2010-2013)
No Diabetes Diagnosis (2014)
Ongoing research at the American Medical Association
© 2018 American Medical Association. All rights reserved.
Current burden of prediabetes
13
84 MILLION ADULTS HAVE PREDIABETES1
9 OF10 DON'T KNOW THEY HAVE PREDIABETES2
1 IN 3 ADULTS HAS PREDIABETES1
1 IN 2 65+age
A reversible condition in which plasma glucose levels are higher than normal but not high enough to diagnose type 2 diabetes
© 2018 American Medical Association. All rights reserved.
Prediabetes diagnosis
© 2018 American Medical Association. All rights reserved.15
Progression from prediabetes to type 2 diabetes
15
© 2018 American Medical Association. All rights reserved.16
Prevention: need to engage the rising risk
Only 3% of our national health expenditure is spent on prevention1
Move beyond keeping the healthy well to target those with identifiable risk factors to prevent progression = rising risk
Stratifying a population
High cost/ utilization
Rising Risk e.g., 15% to 30% chance of progressing from prediabetes to diabetes†
Risk factors
Healthy / low risk
% o
f a P
opul
atio
n
Evidence Base for Diabetes Prevention
© 2018 American Medical Association. All rights reserved.
One solution: National Diabetes Prevention Program
18
Prediabetes is a reversible condition.
The National DPP can help patients lower their risk of developing type 2 diabetes and reduce the likelihood of:
ILLNESS MEDICATION EXPENSE
© 2018 American Medical Association. All rights reserved.
What is the National DPP?
19
Examples of sessions:
1. Eat Well to Prevent T22. Get Active to Prevent T23. Shop and Cook to Prevent T24. Find Time for Fitness5. Eat Well Away from Home6. Stay Motivated to Prevent T27. Manage Stress8. Have Healthy Food You Enjoy
© 2018 American Medical Association. All rights reserved.
Historical starting point: DPP randomized controlled trial
20
DPP Research Study: People with prediabetes who took part in a structured lifestyle change program reduced their risk of developing type 2 diabetes (at average follow-up of 3 years) compared to placebo.
And the lifestyle change program was nearly twice as effective as metformin.
DPPIntensive Lifestyle Change Program
(71% reduction for patients over age 60)
METFORMINGlucose Lowering Drug
(Currently, there is no FDA approval for metformin for the indication of diabetes prevention)
31%riskreduction58%risk
reduction
© 2018 American Medical Association. All rights reserved.
National DPP Lifestyle Change Program
21
Program goal
5%MINIMUM BODYWEIGHT LOSS IN 6 MONTHS
MONTHS OF MAINTENANCE6+
In-person program•Peer-to-peer camaraderie•Group support•Progress reports•CDC-recognized
Online program•Patient flexibility•Complete modules on own schedule•Web/mobile enabled dashboards •CDC-recognized
• Emphasis on prevention, and empowerment
• Lifestyle coach motivates and supports individuals
© 2018 American Medical Association. All rights reserved.
Benefits of the DPP
22
15 FEWER NEW CASES OF DIABETES1
8 FEWER PATIENTS USING ANTI-HYPERTENSIVE MEDICATION2
4 FEWER PATIENTS USING ANTI-LIPID MEDICATION2
DPP clinical impact:(over 3 years, after program completion per 100 high-risk adults)
1. Knowler et al. N Engl J Med 2002;346:393-403.2. The DPP Research Group. Impact of lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
Diabetes Care 2005:28(4):888-894.
© 2018 American Medical Association. All rights reserved.
USPSTF abnormal glucose screening recommendation
23
USPSTF standards suggest testing patients every 3 years.
AGE & BMI
Grade B recommendation• 40-70 age AND• BMI ≥ 25* The American Diabetes Association encourages screening for diabetes at a BMI of ≥ 23 for Asian Americans
© 2018 American Medical Association. All rights reserved.
USPSTF abnormal glucose screening recommendation
24
Family historyFamily history of type 2 diabetes includes first-degree relatives (a person’s parent, sibling or child)
Medical history• Gestational diabetes
• Polycystic ovary syndrome
Racial and ethnic minorities• African Americans
• American Indians or Alaskan Natives• Asian Americans
• Hispanics or Latinos• Native Hawaiians or Pacific Islanders
© 2018 American Medical Association. All rights reserved.
USPSTF abnormal glucose screening recommendation
25
Grade B recommendation
• Screen for abnormal blood glucose with a fasting glucose, hemoglobin A1C or oral glucose tolerance test
• Refer patients with abnormal glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity
© 2018 American Medical Association. All rights reserved.
DPP Benefits Practicing Physicians & Health Systems
Why prioritize diabetes prevention?
26
Allows physicians to offer our patients the intensive lifestyle change counseling they need, but that we don’t have the time/capacity to give
Aligns to value based care trends• Included as
Improvement Activities under QPP (MIPS)
• Aligns with PCMH standards
Medicare reimbursement scheduled to begin 2018
Achieves the IHI Triple (Quadruple) Aim• Better care: Adheres to evidence-based
guidelines for diabetes prevention• Better outcomes: Lowers incidence of
diabetes by 58 percent• Lower cost: Medicare estimated savings
at $2,650 per beneficiary• Improving Care Giver Experiences:
Reduce prevalence of diabetes
© 2018 American Medical Association. All rights reserved.
National Movement
27
© 2018 American Medical Association. All rights reserved.
Challenges Facing Clinical Team
28
The current and growing volume of chronic disease
Lack of time to effectively deliver the intensive counseling needed for lifestyle changes
Social determinants of health often fall outside our scope of influence
Lack of adequate information about community-based resources for diabetes prevention
© 2018 American Medical Association. All rights reserved.29
© 2018 American Medical Association. All rights reserved.30
© 2018 American Medical Association. All rights reserved.
AMA Efforts to Prevent Diabetes
Goal:
Galvanize efforts to increase screening for prediabetes and raise participation in evidence-based diabetes prevention programs
Approach:
• Engage health systems across the U.S. in diabetes prevention
• Help link clinical practices to diabetes prevention programs
• Develop, test and disseminate relevant tools and resources
• Advocate for inclusion of lifestyle interventions in health benefits
31
www.preventdiabetesstat.org
© 2018 American Medical Association. All rights reserved.
Changing Clinical Practice
32
© 2018 American Medical Association. All rights reserved.
AMA diabetes prevention offeringsThe AMA offers a comprehensive program to guide implementation of clinical practice change in order to prevent type 2 diabetes.
33
Engagement Consulting Implementation support (admin)Services
Walk through core decisions
Tools and solutions(examples, not comprehensive)
© 2018 American Medical Association. All rights reserved.
Determine DPP offering
Internal DPP
Partner with community organization
Virtual DPP
34
Something else
© 2018 American Medical Association. All rights reserved.
Physician and care team engagement• Clinic awareness
• Grand rounds
• Online modules
• PI CME (Part IV MoC)
35
www.preventdiabetesstat.org
© 2018 American Medical Association. All rights reserved.
STEPS Forward® and PI CME
36
www.stepsforward.org www.ama-assn.org/education
© 2018 American Medical Association. All rights reserved.
Patient identification
37
© 2018 American Medical Association. All rights reserved.
Patient communications
38
preventidiabetesstat.org and doihaveprediabetes.org
© 2018 American Medical Association. All rights reserved.
Referral process and feedback loop
39
© 2018 American Medical Association. All rights reserved.40
MONTH 1 MONTH 2 MONTH 3 MONTH 4
Secure Organizational
Buy-in
LaunchDPP
Submit CDC Application
Create Snapshot of
Potential Costs/
Benefits
Meeting/Phone Conference with the AMA
Identify Eligible Patients
Initiate Patient Communication
& Messaging
Identify Physician Champion
Develop Physician
Engagement & Education
Development Plan
Develop Referral
Process to DPP
Milestones
CLIENT JOURNEY MAP
AMA Facilitate
Webinar or Co-Present to Physician
Team
Define Reporting Metrics
Secure Class Location/Time
*Visual example; not fully comprehensive of the process in its entirety
Final Class Preparation
Identify and Train DPP Coaches
© 2018 American Medical Association. All rights reserved.
Evaluation
41
Identification
DPP Referral
DPP Enrollment
DPP Participation
CostOutcomesAttendance and Retention
Weight Loss Physical Activity HbA1c Blood Pressure Medications
© 2018 American Medical Association. All rights reserved.
System-wide Diabetes Prevention Strategic Plan
Purpose:
Intermountain will develop and implement a systematic and comprehensive approach to identify individuals at-risk for
diabetes and match them with evidence-based interventions in
an effort to prevent type 2 diabetes.
PROPRIETARY
© 2018 American Medical Association. All rights reserved.
Impact of Coverage:The Case Avoidance Equation
Target 1949 individuals for enrollment (total n=6495)
Cumulative DM incidence at 1 yrs:• DPP vs Controls (2.1% vs 5.0%)• 3% reduction
$6030 difference in healthcare costs for those with T2DM compared to those with prediabetes*
By hitting our enrollment goal, avoid 58 cases of diabetes......indicating a $349,723 savings to the system
*Internal analysis of Intermountain health plan claims
Could Intermountain target a 2018 enrollment goal for our Medicare capitated insurance product?
© 2018 American Medical Association. All rights reserved.
Shared Decision Making Tools
• The use of a decision aid (DA), defined as a tool that makes the clinical decision explicit, describes the options available, and helps people to understand these options as well as their possible benefits and harms, is one way to frame preference-sensitive decisions.
• This is particularly critical for patients with prediabetes, who are often confused about the short-term and long-term risks associated with their asymptomatic condition, are uncertain “what else they can do” to prevent diabetes, and feel “left in mid-air” to fend for themselves PROPRIETARY
© 2018 American Medical Association. All rights reserved.
Shared Decision Aid for Prediabetes
D E L I B E R A T I O N (45 to 60 minute clinical encounter with the pharmacist).
Initial Preferences Informed Preferences
PROPRIETARY
STAGE 1: Talk About Choice
• Step back & describe problem• Offer choice• Justify choice (explain uncertainty,
concept of personal preferences).• Check patient reaction
STAGE 2: Talk About Options
• Check knowledge ①• List options (lifestyle, metformin)
①• Describe options, including harms
and benefits ②• Provide decision support ②• Summarize
STAGE 3: Talk About Decision
• Focus on preferences ③• Elicit a preference ③• Leaning toward decision ④• Offer review ⑤• Make decision ⑥
© 2018 American Medical Association. All rights reserved.
Final Thoughts
46
© 2018 American Medical Association. All rights reserved.
Best practices for enabling physicians and care teams to refer• Raise awareness amongst physicians, care teams and patients through
Ad Council campaign, grand rounds, webinars and CME
• Approach as a process or quality improvement initiative
• “Automate” screening and referrals• Retrospective query to identify those at risk
• Criteria to identify those most at risk/likely to act/likely to be successful
• Referral through EMR
• Build feedback loops so that physicians can discuss progress with their patients
© 2018 American Medical Association. All rights reserved.
Questions
49